Experimental drug tested for debilitating fatigue condition
NCT ID NCT00215813
Summary
This study is testing whether a drug called Ampligen can help people with severe chronic fatigue syndrome. Participants are adults aged 18-70 who have had the condition for at least a year and have significantly reduced quality of life. The study is open-label, meaning everyone knows they're receiving the drug, and participants are responsible for paying the treatment costs themselves.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC FATIGUE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hunter-Hopkins Center, PA
Charlotte, North Carolina, 28210, United States
-
Sierra Internal Medicine
Incline Village, Nevada, 89451, United States
Conditions
Explore the condition pages connected to this study.